Skip to content
Disclosery

ENAVATE SCIENCES GP, LLC

Follow

13F filer, CIK 1953107, New York, NY

ENAVATE SCIENCES GP, LLC reported $176,535,354 across 6 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001415889-25-021852

Period
2025-06-30
Reported value
$177M
Holdings
6
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0001415889-25-021852, largest first. % of portfolio is the value over $176,535,354, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
IMNMIMMUNOME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 3,478,261 shares; 2025Q1: 4,768,583 shares; 2025Q2: 4,768,583 shares 4,768,583$44.3M25.12%0Timeline
SIONSIONNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 2,478,030 shares; 2025Q2: 2,478,030 shares 2,478,030$43M24.35%0Timeline
ZBIOZENAS BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 3,761,359 shares; 2025Q1: 3,761,359 shares; 2025Q2: 3,761,359 shares 3,761,359$36.4M20.65%0Timeline
UPBUPSTREAM BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 2,459,703 shares; 2025Q1: 2,459,703 shares; 2025Q2: 2,459,703 shares 2,459,703$27M15.3%0Timeline
CMPXCOMPASS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 7,788,150 shares; 2025Q1: 7,788,150 shares; 2025Q2: 7,788,150 shares 7,788,150$20.2M11.47%0Timeline
CAMPCAMP4 THERAPEUTICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 3,785,802 shares; 2025Q1: 3,785,802 shares; 2025Q2: 3,785,802 shares 3,785,802$5.49M3.11%0Timeline

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001415889-25-021852 base2025-08-14acceptance time not in the bulk data set